Metastatic Differentiated Thyroid Cancer
2 clinical trials · Condition
◉ Watch Metastatic Differentiated Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry (NCT05299437) | Carlo Chiesa | 2021-05-12 |
| Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer (NCT00654238) | University of Pennsylvania | 2006-02-01 |
Track Metastatic Differentiated Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.